← Back to Search

Yoga for Young Adults with Cancer

N/A
Recruiting
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with cancer between the ages of 18-39 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 years
Awards & highlights

Summary

This trial is testing a yoga program to see if it helps young adults who have had cancer feel better physically and mentally. The program includes exercises and relaxation techniques to reduce stress and improve overall well-being.

Who is the study for?
This trial is for young adults aged 18-39 who have been diagnosed with cancer, are at any stage of treatment or recovery, and can safely do yoga. Participants must be able to understand and complete consent forms, questionnaires, physical assessments, and an interview in English.
What is being tested?
The study is testing a specially developed yoga program designed to improve the physical and psychological well-being of young adults with cancer. This single-group study will assess the effectiveness of the program through various methods including participant feedback.
What are the potential side effects?
Yoga is generally considered safe but may include side effects like muscle soreness or strain. The risk of more serious side effects is low if participants get medical clearance beforehand as required by this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with cancer between 18 and 39 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reach
Secondary study objectives
Adherence
Adverse events
Aerobic endurance
+19 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: YogaExperimental Treatment1 Intervention
Participants receive online, group-based yoga classes 2 times/week for 60 minutes/class over 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Integrative therapies like yoga, meditation, and mindfulness-based stress reduction (MBSR) work by promoting relaxation, reducing stress, and improving emotional well-being. These treatments help manage pain, anxiety, and other symptoms by training the mind to be less reactive to painful sensations and difficult emotions. They also enhance physical outcomes by improving flexibility, strength, and overall physical function. For cancer patients, these mechanisms offer valuable non-pharmacologic options that can complement conventional treatments, potentially improving quality of life and overall treatment outcomes.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
805 Previous Clinical Trials
883,532 Total Patients Enrolled
Canadian Cancer Society (CCS)OTHER
79 Previous Clinical Trials
37,188 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,373 Previous Clinical Trials
26,518,742 Total Patients Enrolled

Media Library

Yoga Clinical Trial Eligibility Overview. Trial Name: NCT05314803 — N/A
Cancer Research Study Groups: Yoga
Cancer Clinical Trial 2023: Yoga Highlights & Side Effects. Trial Name: NCT05314803 — N/A
Yoga 2023 Treatment Timeline for Medical Study. Trial Name: NCT05314803 — N/A
~260 spots leftby Dec 2027